ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced that it will present at the Rodman & Renshaw 14th Annual Healthcare Conference on September 10, 2012, at 3:15 PM Eastern Time at Waldorf Astoria Hotel in New York, NY.
